Stay updated with breaking news from Pharma Bro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A federal appeals court on Tuesday upheld a lifetime ban on Martin Shkreli working in the pharmaceutical industry and ordered him to pay a multimillion-dollar disgorgement fine for illegally hiking drug prices.
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, exits court in New York, US, on Wednesday, Oct. 4, 2023. (Bloomberg / Contributor/Getty Images)(NEW YORK) -- Martin Shkreli's lifetime ban from the pharmaceutical industry was upheld by a federal appeals court in New York on Tuesday. A three-judge panel of the 2nd U.S. Circuit Court of Appeals ruled Shkreli was punished appropriately for antitrust violations. Shkreli increased the price of the antiparasitic drug Daraprim -- an anti-malaria medication often prescribed for HIV patients -- by 4,000%, from $17.50 per pill...
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, exits court in New York, US, on Wednesday, Oct. 4, 2023. (Bloomberg / Contributor/Getty Images)(NEW YORK) -- Martin Shkreli's lifetime ban from the pharmaceutical industry was upheld by a federal appeals court in New York on Tuesday. A three-judge panel of the 2nd U.S. Circuit Court of Appeals ruled Shkreli was punished appropriately for antitrust violations. Shkreli increased the price of the antiparasitic drug Daraprim -- an anti-malaria medication often prescribed for HIV patients -- by 4,000%, from $17.50 per pill...
Judge upholds "Pharma Bro" Martin Shkreli's ban from pharmaceutical industry on Tuesday.
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, exits court in New York, US, on Wednesday, Oct. 4, 2023. (Bloomberg / Contributor/Getty Images)(NEW YORK) -- Martin Shkreli's lifetime ban from the pharmaceutical industry was upheld by a federal appeals court in New York on Tuesday. A three-judge panel of the 2nd U.S. Circuit Court of Appeals ruled Shkreli was punished appropriately for antitrust violations. Shkreli increased the price of the antiparasitic drug Daraprim -- an anti-malaria medication often prescribed for HIV patients -- by 4,000%, from $17.50 per pill...